Dr Reddy’s Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravis We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Sanofi Rilzabrutinib earns orphan designation in EU for IgG4 related disease We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link